CTSB Protein

CTSB Protein

Introduction

Pathway Diagram

```mermaid
flowchart TD
TFEB["TFEB<br/>Transcription Factor"]
SLAMF7["SLAMF7<br/>Signaling Protein"]
CTSB["CTSB<br/>Cathepsin B<br/>Lysosomal Protease"]

ATG12["ATG12<br/>Autophagy Protein"]
TPP1["TPP1<br/>Lysosomal Enzyme"]
GRN["GRN<br/>Progranulin<br/>Growth Factor"]

Phagocytosis["Phagocytosis<br/>Pathway"]
Complement["Complement<br/>Pathway"]
C1QA["C1QA<br/>Complement<br/>Component"]
SPP1["SPP1<br/>Osteopontin<br/>Inflammatory Marker"]

Neurodegeneration["Neurodegeneration<br/>Pathological Process"]
Alzheimer["Alzheimer's<br/>Disease"]
Parkinson["Parkinson's<br/>Disease"]
ALS["Amyotrophic<br/>Lateral Sclerosis"]
Huntington["Huntington's<br/>Disease"]

TFEB -->|"upregulates"| CTSB
SLAMF7 -->|"activates"| CTSB

CTSB -->|"activates"| ATG12
CTSB -->|"associated_with"| TPP1
CTSB -->|"activates"| GRN

CTSB -->|"activates"| Phagocytosis
CTSB -->|"activates"| Complement
CTSB -->|"activates"| C1QA
CTSB -->|"activates"| SPP1

CTSB -->|"activates"| Neurodegeneration
CTSB -->|"associated_with"| Alzheimer
CTSB -->|"associated_with"| Parkinson
CTSB -->|"associated_with"| ALS
CTSB -->|"associated_with"| Huntington

style CTSB fill:#006494
style TFEB fill:#4a1a6b
style SLAMF7 fill:#4a1a6b
style ATG12 fill:#1b5e20
style TPP1 fill:#1b5e20
style GRN fill:#1b5e20
style Phagocytosis fill:#1b5e20
style Complement fill:#ef5350
style C1QA fill:#ef5350
style

CTSB Protein

Introduction

Pathway Diagram

Ctsb Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox .infobox-protein"> [@alzheimers]
<h3>CTSB Protein</h3> [@nih]
<table>
<tr><th>Protein Name</th><td>Cathepsin B</td></tr>
<tr><th>Gene</th><td>[CTSB](/genes/ctsb)</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/P07858" target="_blank">P07858</a></td></tr>
<tr><th>PDB ID</th><td>1HUC, 2IPP, 4P7N</td></tr>
<tr><th>Molecular Weight</th><td>33.8 kDa (proenzyme), 25.2 kDa (mature)</td></tr>
<tr><th>Subcellular Localization</th><td>Lysosome</td></tr>
<tr><th>Protein Family</th><td>Papain family, Cysteine proteases</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">435 edges</a></td>
</tr>
</table>
</div>

Structure

Cathepsin B is a cysteine protease with unique features among cathepsins:

• Propeptide: N-terminal propeptide (residues 1-62) for latency
• Mature enzyme: Two-chain form (heavy chain + light chain)
• Occluding loop: Unique to cathepsin B, blocks active site in some forms
• Active site: Cys29, His199, Asn219 catalytic triad

Normal Function

Cathepsin B is a lysosomal cysteine protease with important physiological functions:

Primary functions:

• Protein degradation: Degrades proteins in lysosomes
• Zymogen activation: Activates other proteases (e.g., procathepsins D and L)
• Extracellular matrix remodeling: Degrades ECM components
• Immune function: Processes antigens for MHC presentation

• Synthesized as inactive proenzyme
• Activated by low pH in lysosomes
• Inhibited by cystatin C and other protease inhibitors

Role in Neurodegeneration

Alzheimer's Disease

• [Aβ](/proteins/amyloid-beta) metabolism: CTSB cleaves Aβ and may reduce aggregation
• [Tau](/proteins/tau) pathology: May degrade hyperphosphorylated tau
• Expression: Increased in AD brain
• Therapeutic angle: Enhancing CTSB could reduce Aβ accumulation

Parkinson's Disease

• CTSB expression is altered in PD substantia nigra
• May degrade [α-synuclein](/proteins/alpha-synuclein)
• Role in lysosomal dysfunction

Lysosomal Storage Disorders

• CTSB deficiency leads to neuronal ceroid lipofuscinosis (CLN10)
• Accumulation of lipofuscin in [neurons](/entities/neurons)

Stroke and Trauma

• Released extracellularly after injury
• Contributes to tissue damage

Therapeutic Targeting

Inhibitors

• CA-074: Selective cathepsin B inhibitor
• E-64: Broad cysteine protease inhibitor

Activators

• Compounds that enhance CTSB expression or activity
• Gene therapy approaches

Clinical Status

• CTSB inhibitors in development for cancer and fibrosis
• Potential for neurodegenerative disease applications

Key Publications

Background

The study of Ctsb Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Cross-references

• Gene: [CTSB](genes/ctsb)
• Proteins: [CST3 Protein](proteins/cystatin-c-protein), [Cathepsin D|CTSD Protein]
• Diseases: [Alzheimer's Disease](diseases/alzheimers), [Parkinson's Disease](diseases/parkinsons)
• Pathways: [Lysosomal Dysfunction](mechanisms/lysosomal-dysfunction), [Proteolysis|Proteolysis]

Overview

CTSB encodes Cathepsin B, a lysosomal cysteine protease involved in protein degradation. Implicated in neurodegenerative diseases through abnormal processing of disease-related proteins.

See Also

• Cathepsin B - Enzyme overview
• CTSB Gene - Gene page
• Lysosomal Pathway - Degradation
• Alzheimer Disease - AD disease

External Links

• [CTSB - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/1508)
• [Cathepsin B - UniProt](https://www.uniprot.org/uniprot/P07846)

References